Logo image of 6D81.DE

DUPONT DE NEMOURS INC (6D81.DE) Stock Fundamental Analysis

FRA:6D81 - Deutsche Boerse Ag - US26614N1028 - Common Stock - Currency: EUR

58.86  +1.33 (+2.31%)

Fundamental Rating

5

Overall 6D81 gets a fundamental rating of 5 out of 10. We evaluated 6D81 against 61 industry peers in the Chemicals industry. 6D81 has an excellent profitability rating, but there are some minor concerns on its financial health. 6D81 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year 6D81 was profitable.
6D81 had a positive operating cash flow in the past year.
6D81 had positive earnings in 4 of the past 5 years.
In the past 5 years 6D81 always reported a positive cash flow from operatings.
6D81.DE Yearly Net Income VS EBIT VS OCF VS FCF6D81.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

1.2 Ratios

With a decent Return On Assets value of 1.92%, 6D81 is doing good in the industry, outperforming 62.90% of the companies in the same industry.
Looking at the Return On Equity, with a value of 3.01%, 6D81 is in line with its industry, outperforming 58.06% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 3.85%, 6D81 is in the better half of the industry, outperforming 64.52% of the companies in the same industry.
6D81 had an Average Return On Invested Capital over the past 3 years of 3.52%. This is below the industry average of 6.29%.
The 3 year average ROIC (3.52%) for 6D81 is below the current ROIC(3.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.92%
ROE 3.01%
ROIC 3.85%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
6D81.DE Yearly ROA, ROE, ROIC6D81.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

6D81 has a Profit Margin of 5.68%. This is in the better half of the industry: 6D81 outperforms 72.58% of its industry peers.
In the last couple of years the Profit Margin of 6D81 has grown nicely.
6D81 has a Operating Margin of 15.15%. This is amongst the best in the industry. 6D81 outperforms 85.48% of its industry peers.
6D81's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 36.59%, 6D81 perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
6D81's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.15%
PM (TTM) 5.68%
GM 36.59%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
6D81.DE Yearly Profit, Operating, Gross Margins6D81.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 6D81 is destroying value.
Compared to 1 year ago, 6D81 has less shares outstanding
Compared to 5 years ago, 6D81 has less shares outstanding
The debt/assets ratio for 6D81 has been reduced compared to a year ago.
6D81.DE Yearly Shares Outstanding6D81.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
6D81.DE Yearly Total Debt VS Total Assets6D81.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

6D81 has an Altman-Z score of 0.94. This is a bad value and indicates that 6D81 is not financially healthy and even has some risk of bankruptcy.
6D81's Altman-Z score of 0.94 is on the low side compared to the rest of the industry. 6D81 is outperformed by 77.42% of its industry peers.
6D81 has a debt to FCF ratio of 5.66. This is a neutral value as 6D81 would need 5.66 years to pay back of all of its debts.
6D81 has a better Debt to FCF ratio (5.66) than 69.35% of its industry peers.
6D81 has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
6D81 has a better Debt to Equity ratio (0.23) than 72.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.66
Altman-Z 0.94
ROIC/WACC0.46
WACC8.29%
6D81.DE Yearly LT Debt VS Equity VS FCF6D81.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 1.33 indicates that 6D81 should not have too much problems paying its short term obligations.
6D81 has a worse Current ratio (1.33) than 69.35% of its industry peers.
A Quick Ratio of 0.88 indicates that 6D81 may have some problems paying its short term obligations.
6D81 has a worse Quick ratio (0.88) than 64.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.88
6D81.DE Yearly Current Assets VS Current Liabilites6D81.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.66% over the past year.
Measured over the past years, 6D81 shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.50% on average per year.
The Revenue has been growing slightly by 2.64% in the past year.
6D81 shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.31% yearly.
EPS 1Y (TTM)25.66%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%30.38%
Revenue 1Y (TTM)2.64%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%4.61%

3.2 Future

6D81 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.40% yearly.
The Revenue is expected to grow by 5.31% on average over the next years.
EPS Next Y8.35%
EPS Next 2Y9.15%
EPS Next 3Y10%
EPS Next 5Y11.4%
Revenue Next Year3.07%
Revenue Next 2Y3.8%
Revenue Next 3Y4.44%
Revenue Next 5Y5.31%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
6D81.DE Yearly Revenue VS Estimates6D81.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
6D81.DE Yearly EPS VS Estimates6D81.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.49, which indicates a correct valuation of 6D81.
Based on the Price/Earnings ratio, 6D81 is valued a bit cheaper than the industry average as 79.03% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.18. 6D81 is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 13.77, 6D81 is valued correctly.
72.58% of the companies in the same industry are more expensive than 6D81, based on the Price/Forward Earnings ratio.
6D81 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.49
Fwd PE 13.77
6D81.DE Price Earnings VS Forward Price Earnings6D81.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

62.90% of the companies in the same industry are more expensive than 6D81, based on the Enterprise Value to EBITDA ratio.
66.13% of the companies in the same industry are more expensive than 6D81, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.04
EV/EBITDA 10.83
6D81.DE Per share data6D81.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
6D81 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.86
PEG (5Y)N/A
EPS Next 2Y9.15%
EPS Next 3Y10%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.48%, 6D81 has a reasonable but not impressive dividend return.
The stock price of 6D81 dropped by -20.32% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.10, 6D81 pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, 6D81 has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.48%

5.2 History

The dividend of 6D81 decreases each year by -33.98%.
Dividend Growth(5Y)-33.98%
Div Incr Years4
Div Non Decr Years4
6D81.DE Yearly Dividends per share6D81.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

90.33% of the earnings are spent on dividend by 6D81. This is not a sustainable payout ratio.
DP90.33%
EPS Next 2Y9.15%
EPS Next 3Y10%
6D81.DE Yearly Income VS Free CF VS Dividend6D81.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B
6D81.DE Dividend Payout.6D81.DE Dividend Payout, showing the Payout Ratio.6D81.DE Dividend Payout.PayoutRetained Earnings

DUPONT DE NEMOURS INC

FRA:6D81 (5/2/2025, 7:00:00 PM)

58.86

+1.33 (+2.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners72.82%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap24.63B
Analysts80.74
Price Target78.29 (33.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.48%
Yearly Dividend1.32
Dividend Growth(5Y)-33.98%
DP90.33%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.65%
Min EPS beat(2)11.31%
Max EPS beat(2)11.99%
EPS beat(4)4
Avg EPS beat(4)13.12%
Min EPS beat(4)10.57%
Max EPS beat(4)18.61%
EPS beat(8)6
Avg EPS beat(8)7.43%
EPS beat(12)10
Avg EPS beat(12)8.62%
EPS beat(16)14
Avg EPS beat(16)8.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.71%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-2.15%
Revenue beat(4)2
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-3.27%
Max Revenue beat(4)1.17%
Revenue beat(8)2
Avg Revenue beat(8)-1.76%
Revenue beat(12)3
Avg Revenue beat(12)-1.49%
Revenue beat(16)3
Avg Revenue beat(16)-7.04%
PT rev (1m)-15.8%
PT rev (3m)-16.8%
EPS NQ rev (1m)-0.39%
EPS NQ rev (3m)0.84%
EPS NY rev (1m)-2.12%
EPS NY rev (3m)-1.6%
Revenue NQ rev (1m)-0.16%
Revenue NQ rev (3m)-0.67%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE 15.49
Fwd PE 13.77
P/S 2.26
P/FCF 22.04
P/OCF 15.13
P/B 1.2
P/tB 19.77
EV/EBITDA 10.83
EPS(TTM)3.8
EY6.46%
EPS(NY)4.27
Fwd EY7.26%
FCF(TTM)2.67
FCFY4.54%
OCF(TTM)3.89
OCFY6.61%
SpS26.09
BVpS49.19
TBVpS2.98
PEG (NY)1.86
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 3.01%
ROCE 5.89%
ROIC 3.85%
ROICexc 4.08%
ROICexgc 15.21%
OM 15.15%
PM (TTM) 5.68%
GM 36.59%
FCFM 10.24%
ROA(3y)5.74%
ROA(5y)5.44%
ROE(3y)8.95%
ROE(5y)8.73%
ROIC(3y)3.52%
ROIC(5y)3.04%
ROICexc(3y)3.85%
ROICexc(5y)3.28%
ROICexgc(3y)12.84%
ROICexgc(5y)9.92%
ROCE(3y)5.39%
ROCE(5y)4.66%
ROICexcg growth 3Y25.22%
ROICexcg growth 5Y11.83%
ROICexc growth 3Y9.23%
ROICexc growth 5Y14.61%
OM growth 3Y0.59%
OM growth 5Y3.81%
PM growth 3Y-52.04%
PM growth 5Y12.01%
GM growth 3Y0.02%
GM growth 5Y0.86%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 5.66
Debt/EBITDA 1.73
Cap/Depr 48.49%
Cap/Sales 4.67%
Interest Coverage 4.76
Cash Conversion 60.16%
Profit Quality 180.37%
Current Ratio 1.33
Quick Ratio 0.88
Altman-Z 0.94
F-Score8
WACC8.29%
ROIC/WACC0.46
Cap/Depr(3y)55.14%
Cap/Depr(5y)53.03%
Cap/Sales(3y)5.17%
Cap/Sales(5y)6.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.66%
EPS 3Y-1.04%
EPS 5Y-5.5%
EPS Q2Q%30.38%
EPS Next Y8.35%
EPS Next 2Y9.15%
EPS Next 3Y10%
EPS Next 5Y11.4%
Revenue 1Y (TTM)2.64%
Revenue growth 3Y-0.48%
Revenue growth 5Y-4.31%
Sales Q2Q%4.61%
Revenue Next Year3.07%
Revenue Next 2Y3.8%
Revenue Next 3Y4.44%
Revenue Next 5Y5.31%
EBIT growth 1Y8.63%
EBIT growth 3Y0.11%
EBIT growth 5Y-0.66%
EBIT Next Year32.55%
EBIT Next 3Y15.26%
EBIT Next 5Y13.76%
FCF growth 1Y-2.39%
FCF growth 3Y-3.02%
FCF growth 5YN/A
OCF growth 1Y-3.7%
OCF growth 3Y-6.79%
OCF growth 5Y5.56%